Bladder and Ureter Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Bladder and Ureter Cancer Drug Development Pipeline Review, 2017

  • Report
  • 150 Pages
From
Pontine Glioma (DIPG): Drug Development Pipeline Study, H1 2018 - Product Thumbnail Image

Pontine Glioma (DIPG): Drug Development Pipeline Study, H1 2018

  • Report
  • 65 Pages
From
Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 834 Pages
From
Bladder Cancer - Pipeline Review, H2 2017 - Product Thumbnail Image

Bladder Cancer - Pipeline Review, H2 2017

  • Report
  • 937 Pages
From
Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2018 - Product Thumbnail Image

Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2018

  • Report
  • 1759 Pages
From
Pontine Glioma - Pipeline Review, H1 2018 - Product Thumbnail Image

Pontine Glioma - Pipeline Review, H1 2018

  • Report
  • 257 Pages
From
Medulloblastoma - Pipeline Review, H2 2017 - Product Thumbnail Image

Medulloblastoma - Pipeline Review, H2 2017

  • Report
  • 197 Pages
From
Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016 - Product Thumbnail Image

Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016

  • Report
  • 420 Pages
From
Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016 - Product Thumbnail Image

Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

  • Report
  • 434 Pages
From
Brain Cancer - Pipeline Review, H2 2015 - Product Thumbnail Image

Brain Cancer - Pipeline Review, H2 2015

  • Report
  • 311 Pages
From
Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015 - Product Thumbnail Image

Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015

  • Report
  • 346 Pages
From
Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016 - Product Thumbnail Image

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

  • Report
  • 266 Pages
From
Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Pipeline Review, H1 2018 - Product Thumbnail Image

Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Pipeline Review, H1 2018

  • Report
  • 55 Pages
From
Cancer Stem Cell Therapies Market, 2017-2030 - Product Thumbnail Image

Cancer Stem Cell Therapies Market, 2017-2030

  • Report
  • 270 Pages
From
Interleukin-2 (IL-2) Inhibitor -Pipeline Insight, 2018 - Product Thumbnail Image

Interleukin-2 (IL-2) Inhibitor -Pipeline Insight, 2018

  • Drug Pipelines
  • 60 Pages
From
Interleukin-2 (IL-2) Receptor Agonist -Pipeline Insight, 2018 - Product Thumbnail Image

Interleukin-2 (IL-2) Receptor Agonist -Pipeline Insight, 2018

  • Drug Pipelines
  • 60 Pages
From
Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016 - Product Thumbnail Image

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

  • Report
  • 286 Pages
From
Pancreatic Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H1 2018

  • Report
  • 2509 Pages
From
Colon Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Colon Cancer - Pipeline Review, H1 2018

  • Report
  • 782 Pages
From
Melanoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Melanoma - Pipeline Review, H1 2018

  • Report
  • 2011 Pages
From
Loading Indicator
adroll